Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bristol-Myers Squibb buy JPMorgan Chase & Co.

Start price
€56.36
31.07.26 / 50%
Target price
€63.42
31.07.27
Performance (%)
-1.92%
Price
€55.28
12.08.26
Summary
This prediction is currently active. With a performance of -1.92%, the BUY prediction by JPMorgan_Chase___Co_ is trending in the wrong direction. This prediction currently runs until 31.07.27. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w
Bristol-Myers Squibb 0.363%
iShares Core DAX® 0.625%
iShares Nasdaq 100 1.160%
iShares Nikkei 225® 2.356%
iShares S&P 500 0.631%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) -1.92%
Target price 63.422
Change
Ends at 31.07.27

Bristol Myers Squibb (BMY) had its price target raised by JPMorgan Chase & Co. from $67.00 to $73.00. They now have an "overweight" rating on the stock.
Ratings data for BMY provided by MarketBeat